Mahmood Razavi Selected Research

Hemophilia B (Haemophilia B)

3/2006

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mahmood Razavi Research Topics

Disease

1	Congenital Abnormalities (Deformity) 08/2023
1	Hyperplasia 11/2022
1	Ischemia 11/2022
1	Arteriovenous Fistula 01/2022
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 01/2021
1	Hemophilia A (Haemophilia) 03/2006
1	Hemophilia B (Haemophilia B) 03/2006
1	Aneurysm (Aneurysms) 01/2004
1	Pain (Aches) 08/2002
1	Edema (Dropsy) 08/2002
1	Pathologic Constriction (Stenosis) 08/2002
1	Lymphedema (Milroy Disease) 08/2002

Drug/Important Bio-Agent (IBA)

1	temsirolimus FDA Link 11/2022
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 03/2006
1	EnbucrilateIBA 01/2004

Therapy/Procedure

3	Stents 08/2023 - 08/2002
1	Surgical Amputation (Amputations) 11/2022
1	Endovascular Procedures 01/2021
1	Therapeutics 08/2002
1	Catheters 08/2002